Sarcopenia and clinical presentation

Sarcopenia and clinical presentation

Sarcopenia is characterized by the progressive generalized loss of muscle function, quality, strength and mass. Although it is known as a primary geriatric disease, it may also develop in younger individuals secondary to immobilization, malnutrion and cachexia. The exact etiology is unknown, but the most commonly suggested contributory factors are a decrease in protein synthesis, mitochondrial dysfunction, reactive oxygen products, chronic inflammation, nutritional deficiency, loss of perfusion, age-related neuromuscular alterations, decrease in sex hormone, growth hormone (GH), insulin-like growth factor (IGF-1) and vitamin D levels together with physical inactivity.There are severe negative effects on quality of life and the individual’s socio-economic status and thus, sarcopenia is a significant public health problem. Sarcopenia is strongly correlated with the increased fragility that develops in the elderly and is a significant risk factor and also an indicator of disability and mortality. The evaluation of muscle strength and physical performance is mandatory for the diagnosis of sarcopenia. Despite the lack of a definitive treatment method, the most commonly accepted approaches include physical activity, nutritional supplementation therapy, and hormonal and new pharmacological agents. In this review sarcopenia, which is a common but sometimes misdiagnosed condition in clinical practice, is discussed in the light of current knowledge.

___

  • Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci 2003;58:11-9.3.
  • Lynch JE, Henderson NR, Ramage L, McMurdo ME, Witham MD. Association between statin medication use and improved outcomes during inpatient rehabilitation in older people. Age Ageing 2012;41:260-2.
  • Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging 2010;5:217-28.
  • Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J. The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2014;99(11):4336-45.
  • Zachwieja JJ, Toffolo G, Cobelli C, Bier DM, Yarasheski KE. Resistance exercise ang growth hormone administration in older men: effect on insulin sensitivity and secretion during a stablelable intravenosus glucose tolerance test. Metabolism 1996;45:254-60.
  • Waters DL, Baumgartner RN, Garry PJ, Vellas BAdvangates of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010;5:259-70.
  • Sullivan DH, Roberson PK, Johnson LE, Bishara O, Evans WJ, Smith ES. Effects of muscle strength training and testosteron in frail elderly men. Med Sci Sports Sci 2005;37:1664-72.
  • Denison HJ, Cooper C, Sayer AA, Robinson SM. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging 2015;10:859-69.
  • Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 2000;85:4481-90.
  • Tieland M, van de Rest O, Dirks ML, van der Zwaluw N, Mensink M, van Loon LJ. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:720-6.
  • C.P.Sharp, D.R.Pearson.’’Amino acid supplements and recovery from high-intensity resistamce training,’’journal of Strength-Conditioning Research 2010;24(4):1125-30.
  • Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE. Society for Sarcopenia, Cachexia, and Wasting Disease. Nutritional recommendations fort he management of sarcopenia. J Am Med Dir Assoc 2010;11:391-6.
  • Rondanelli M, Faliva M, Monteferrario F, Peroni G, Repaci E, Allieri F, Perna S. Novel insights on nutrient management of sarcopenia in elderly. Biomed Res Int 2015;2015:524948.
  • J. Bauer, G. Biolo, T. Cederholm, Cesari M, Cruz-Jentoft AJ, Morley JE. “Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group,” Journal of the American Medical Directors Association 2013;14(8):542–559.
  • American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 2009;41(3):687-708.
  • Cadore EL, Ezquierdo M. New strategies for the concurrent strength-, power-, and endurance-training prescription in elderly individuals. J Am Med Dir Assoc 2013;14:623-4.
  • Fiatarone MA, O’Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME. Exercise training and nutritional supplemen tation for physical frailty in very old people. N Eng J Med 1994;330:1769-75.
  • Taafe DR, Duret C, Wheeler S. Once-weekly resistance exercise improves muscle strenght and neuromuscular performance in older adults. J Am Geriatr Soc 1999;47:1208-14.
  • Kemmler W, Von Stengel S. Alternative exercise Technologies to fihgt against sarcopenia at old age: A series of studies and review. J Aging Res 2012;2012:109-13.
  • Eyigör S, Kutsal YG. Yaşlılarda Progresif Yeti Kaybı ve Kırılganlık Nedeni: Sarkopeni. Turkish Journal of Geriatrics 2013;16:454-63.
  • Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the’’get-up and go’’ test. Arch Phys Med Rehabil 1986;67:387-9.
  • Cesari M, Kritchevsky SB, Newman AB, Simonsick EM, Harris TB, Penninx BW. Health, Aging and Body Composition Study. Added value of physical performance measures in predicting adverse health- related events: results from the health, aging and body composition study. J am Geriatr Soc 2009;57:251-9.
  • Working Group on Functional Outcome Measures for Cinical Trials Functional outcomes for clinical trials in frail older persons: time to bo moving. J Gerontol A Biol Sci Med Sci 2008;63:160-4.
  • Carmeli E, Imam B, Merrick J. The relationship of pre- sarcopenia and sarcopenia with functional decline in individuals with intellectual disability. Arch Gerontol Geriatr 2012;55:181-5.
  • Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003;95:1851-60.
  • Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D. Sarcopenia, calf circumference and physical function of elderly women: a Cross- sectional study. J Am Geriatr Soc 2003;51:1120-4.
  • Martin AD, Spenst LF, Drinkwater DT, Clarys JP. Anthropometric estimation of muscle mass in men. Med Sci Sports Exerc 1990;22:729-33.
  • Halil M, Ülger Z, Arıoğul S. Sarkopeniye yaklaşım. Hacettepe Tıp Dergisi 2011;42:123-32.
  • Lee WJ, Liu LK, Peng LN. Comparisons of sarcopenia defined by IWGd EWGSOP criteria among older people: results from the I-Lan Longitudinal aging study. J Am Med Dir Assoc 2013;14(7):1-7.
  • Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical imoedance analysis. J Appl Physiol 2000;89:465-71.
  • Woodrow G. Body Composition analysis techniques in the aged adult indications and limitations. Curr Opin Clin Nutr Metab Care 2009;12:8-14.
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F. Sarcopenia: European consensus on fefinition and diagnosis: Report of the European Working Group on Sarcopenia in Older People Age Ageing 2010;39:412-23.
  • Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009;(3):CD002759.
  • Burton LA, McMurdo ME, Struthers AD. Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people? Clin Endocrinol (Oxf) 2011;75:725-9.
  • Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord 2012;13:71-7.
  • Brink M, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clın Invest 1996;97:2509-16.
  • Van Den Beld WA, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavaible serum testosteron and estradiol and their relationships with muscle stregti bone density, and body composition in elderly men. J Clin Endocrin Metab 2000;85:3276-82.
  • Thornell LE, Lindstrom M, Renault V, Mouly V, Butler- Browne GS. Satellite cells and training in the elderly. Scand J Med Sci Sports 2003;13:48-55.
  • Greenlund LJS, Nair KS: Sarcopenia-consequens, mechanisms, and potential therapies. Mech Ageing Develop 2003;124:287-99.
  • Morleyy JE: Anorexia, body composition, and ageing. Curr Opin Clin Nutr Metab Care 2001;4:9-13.
  • Schaap LA, Pluijm SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass and strenght. Am J Med 2006;119(526):9-17.
  • Fulle S, Protasi F, Di tano G, Pietrangelo T, Beltramin A, Boncompagni S, Vecchiet L, Fanò G The contribution of reactive oxygen species to sarcopenia and muscle ageing. Experimental Gerontol 2004;39:17-24.
  • Russ DW, Kent-Braun JA: IS skeletal muscle oxidative capacity decreased in old age? Sports Med 2004;34:221-9.
  • Balagopal P, Rooyackers OE, Adey DB, Ades PA, Nair KS Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol 1997;273:790-800.
  • Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia: etiology, clinical consequens, intervention and assessment. Osteoporosis Int 2010;21:543-59.
  • Cederholm TE, Bauer JM, Boirie Y, Schneider SM, Sieber CC, Rolland Y. Toward a definition of sarcopenia. Clin Geriatr Med 2011;27(3):341-53.
  • Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147(8):755-63.
  • Rosenberg I. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989;50:1231-3.